$AFL

AFLAC INC (AFL): Results of Operations and Financial Condition

AFLAC INC (AFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 afl063026-financialsupplem.htm EX-99.2 Document Final 08/06/2026 Financial Supplement Second Quarter 2026 This document is a statistical supplement to Aflac’s quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you

Original reporting
Published Aug 6, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AFL
Neutral
medium confidence
Mentioned
$AFL
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AFLNeutralLow
01

Why it matters

The key new tradable content is the detailed Q2 2026 segment and consolidated financial tables (adjusted earnings, net earnings, and per-share metrics) plus clarification that LDTI adoption changes deferred profit liability presentation without impacting net earnings.

02

Market read

For AFL, this supplement increases transparency into Q2 2026 earnings components and segment performance, but the excerpt does not show new guidance, a deal, or a regulatory action.

03

What to watch

If the market had not fully digested segment adjusted earnings, operating ratios, or investment results tables, the supplement could still shift near-term expectations for underwriting and investment income trends.

Relevance 7/10Novelty 4/10Timing: filed after market close, for Q2 2026 results supplement

Background

The document is Aflac Incorporated’s SEC Form 8-K (Item 2.02) attaching a financial supplement for its quarterly earnings release, including non-U.S. GAAP adjusted measures and LDTI accounting presentation.

Company-level read

Ticker impact

$AFLNeutralMedium confidence
Context

Aflac’s 8-K includes its Q2 2026 financial supplement with segment adjusted earnings and U.S. and Japan operating metrics.

Expected impact

Near-term price impact is likely limited unless the supplement’s numbers differ materially from what the market already priced from the earnings release.

Evidence & confidence

This is an SEC 8-K statistical supplement (Item 2.02) with detailed tables and accounting presentation context; it is informative but not a new earnings release or guidance change in the provided text.

Market effects

Adds incremental transparency into insurer earnings drivers (investment income, claims, reserve remeasurement) and LDTI-related presentation for long-duration contracts.

Highlights Aflac Japan and Aflac U.S. segment performance and yen/dollar sensitivity tables, relevant for regional insurer sentiment.

Limited global spillover; primarily company-specific disclosure for a U.S. insurer.

Counterpoint

Because the excerpt emphasizes accounting presentation (LDTI) and statistical tables, traders may discount it versus the headline earnings release and focus on any separate guidance or management commentary not shown here.

Key entities

  • Aflac Incorporated

    Subject issuer filing an 8-K with a Q2 2026 financial supplement and segment adjusted results.

  • Financial Accounting Standards Board (FASB) ASU 2018-12 / LDTI

    Long-duration targeted improvements adopted by Aflac as of Jan 1, 2023, affecting presentation of deferred profit liability changes.

Related articles

$AFLMed

Aflac: Q2 Earnings Snapshot

Aflac Inc. (AFL) reported Q2 net income of $825 million, or $1.63 per share. Adjusted earnings were $1.75 per share, below Zacks’ average estimate of $1.77. Revenue was $4.12 billion, with adjusted revenue of $4.22 billion versus $4.19 billion expected. Shares closed at $126.23.

$TRVMed

Three 'Dividend Aristocrats' on Josh Brown's list in July's hottest sector

CNBC Pro’s Josh Brown and Sean Russo highlight three insurance “Dividend Aristocrats”: Travelers (TRV), Chubb (CB), and Aflac (AFL). Travelers reported Q2 core EPS $10.04 vs ~$5.39 consensus, with $2.2B income and AI-linked claims improvements; shares rose ~8%. Chubb and Aflac are noted for long dividend growth streaks and recent operating updates.

$AFLMed

Morgan Stanley Lifts Aflac (AFL) PT to $125 on Solid Insurance Trends

The article discusses AI’s potential economic impact, citing Elon Musk’s prediction of 10 billion humanoid robots by 2040 and a $250 trillion value estimate. It also claims Morgan Stanley raised its Aflac (AFL) price target to $125, and promotes newsletter subscriptions tied to an “underdog” stock priced around $3, alleging $100 million in waste cuts and “400% upside.”

$AFLMedAI 8/10

Morgan Stanley Lifts Aflac (AFL) PT to $125 on Solid Insurance Trends

Morgan Stanley raised its Aflac (AFL) price target to $125 from $120 and kept an Equal Weight rating, citing generally strong Q1 life insurance results, expected earnings momentum through 2026, steady international operations, and improving mortality trends. Separately, Piper Sandler cut its target to $125 from $130, citing Q1 earnings below estimates due to weaker Japan performance, though it noted improving Japan benefit ratios and strong distribution.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.